Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
复制标题
DOI:
10.1016/s1077-9108(08)79091-1
复制
发表时间:
2009
期刊:
影响因子:
--
通讯作者:
F.A.M. Bordonaba
中科院分区:
文献类型:
--
作者:
F.A.M. Bordonaba